ANTIPLATELET EFFECTS OF ORAL DILTIAZEM, PROPRANOLOL, AND THEIR COMBINATION

被引:12
作者
RING, ME [1 ]
CORRIGAN, JJ [1 ]
FENSTER, PE [1 ]
机构
[1] UNIV ARIZONA,MED CTR,DEPT PAEDIAT,TUCSON,AZ 85724
关键词
D O I
10.1111/j.1365-2125.1987.tb03220.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:615 / 620
页数:6
相关论文
共 29 条
[11]   EFFECTS OF VERAPAMIL AND NISOLDIPINE ON HUMAN-PLATELETS - INVIVO AND INVITRO STUDIES [J].
JONES, CR ;
PASANISI, F ;
ELLIOTT, HL ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (03) :191-196
[12]  
KEBER I, 1979, BRIT J CLIN PHARMACO, V7, P287, DOI 10.1111/j.1365-2125.1979.tb00934.x
[13]  
KENNY J, 1984, J AM COLL CARDIOL, V3, P482
[14]   BETA-ADRENOCEPTOR ANTAGONISTS AND HUMAN-PLATELETS - RELATIONSHIP OF EFFECTS TO LIPID SOLUBILITY [J].
KERRY, R ;
SCRUTTON, MC ;
WALLIS, RB .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (16) :2615-2622
[15]  
KIYOMOTO A, 1983, CIRC RES, V52, P115
[16]   CLINICAL EFFICACY OF VERAPAMIL ALONE AND COMBINED WITH PROPRANOLOL IN TREATING PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS [J].
LEON, MB ;
ROSING, DR ;
BONOW, RO ;
LIPSON, LC ;
EPSTEIN, SE .
AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (01) :131-139
[17]   PLATELETS AND PROSTAGLANDINS IN CORONARY-ARTERY DISEASE - RATIONALE FOR USE OF PLATELET-SUPPRESSIVE DRUGS [J].
MEHTA, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (20) :2818-2823
[18]   EFFECTS OF PROPRANOLOL THERAPY ON PLATELET-RELEASE AND PROSTAGLANDIN GENERATION IN PATIENTS WITH CORONARY HEART-DISEASE [J].
MEHTA, J ;
MEHTA, P .
CIRCULATION, 1982, 66 (06) :1294-1298
[19]   INFLUENCE OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL ON PLATELET-AGGREGATION AND THROMBOXANE-A2 GENERATION [J].
MEHTA, J ;
MEHTA, P ;
OSTROWSKI, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :559-564
[20]   PLATELET-AGGREGATION IN AORTIC AND CORONARY VENOUS-BLOOD IN PATIENTS WITH AND WITHOUT CORONARY-DISEASE .3. ROLE OF TACHYCARDIA STRESS AND PROPRANOLOL [J].
MEHTA, J ;
MEHTA, P ;
PEPINE, CJ .
CIRCULATION, 1978, 58 (05) :881-886